Compile Data Set for Download or QSAR
maximum 50k data
Found 59 with Last Name = 'cao' and Initial = 'w'
TargetCarbonic anhydrase 9(Homo sapiens (Human))
University of Florida

LigandPNGBDBM10875(5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide...)
Affinity DataKi:  1nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarbonic anhydrase 2(Homo sapiens (Human))
University of Florida

LigandPNGBDBM10882(6-ethoxy-1,3-benzothiazole-2-sulfonamide | CHEMBL1...)
Affinity DataKi: <1nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
TargetCarbonic anhydrase 2(Homo sapiens (Human))
University of Florida

LigandPNGBDBM10882(6-ethoxy-1,3-benzothiazole-2-sulfonamide | CHEMBL1...)
Affinity DataKi: <1nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
TargetCarbonic anhydrase 2(Homo sapiens (Human))
University of Florida

LigandPNGBDBM10875(5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide...)
Affinity DataKi:  1.10nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
TargetCarbonic anhydrase 2(Homo sapiens (Human))
University of Florida

LigandPNGBDBM10875(5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide...)
Affinity DataKi:  2nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
TargetCarbonic anhydrase 9(Homo sapiens (Human))
University of Florida

LigandPNGBDBM10880(AZA | AZA2 | AZM acetazolamide | Acerazolamide, AA...)
Affinity DataKi:  3nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarbonic anhydrase 2(Homo sapiens (Human))
University of Florida

LigandPNGBDBM10880(AZA | AZA2 | AZM acetazolamide | Acerazolamide, AA...)
Affinity DataKi:  4.90nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
TargetCarbonic anhydrase 2(Homo sapiens (Human))
University of Florida

LigandPNGBDBM50108567(5-Phenylmethanesulfonylamino-[1,3,4]thiadiazole-2-...)
Affinity DataKi:  7nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarbonic anhydrase 2(Homo sapiens (Human))
University of Florida

LigandPNGBDBM50108567(5-Phenylmethanesulfonylamino-[1,3,4]thiadiazole-2-...)
Affinity DataKi:  8.80nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarbonic anhydrase 9(Homo sapiens (Human))
University of Florida

LigandPNGBDBM92939(Methazolamide, MZM)
Affinity DataKi:  9nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCarbonic anhydrase 9(Homo sapiens (Human))
University of Florida

LigandPNGBDBM50108567(5-Phenylmethanesulfonylamino-[1,3,4]thiadiazole-2-...)
Affinity DataKi:  9nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarbonic anhydrase 2(Homo sapiens (Human))
University of Florida

LigandPNGBDBM10880(AZA | AZA2 | AZM acetazolamide | Acerazolamide, AA...)
Affinity DataKi:  10.1nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
TargetCarbonic anhydrase 2(Homo sapiens (Human))
University of Florida

LigandPNGBDBM92939(Methazolamide, MZM)
Affinity DataKi:  11.4nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCarbonic anhydrase 2(Homo sapiens (Human))
University of Florida

LigandPNGBDBM92939(Methazolamide, MZM)
Affinity DataKi:  11.8nMAssay Description:Inhibition assay using carbonic anhydrases.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395784(US10308654, Example 12)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395785(US10308654, Example 13)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395786(US10308654, Example 14)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395787(US10308654, Example 15)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395798(US10308654, Example 26)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395788(US10308654, Example 16)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395799(US10308654, Example 27)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395789(US10308654, Example 17)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395796(US10308654, Example 24)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395795(US10308654, Example 23)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395797(US10308654, Example 25)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395801(US10308654, Example 29)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395793(US10308654, Example 21)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395790(US10308654, Example 18)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395791(US10308654, Example 19)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395792(US10308654, Example 20)
Affinity DataIC50: <10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395800(US10308654, Example 28)
Affinity DataIC50:  55nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395794(US10308654, Example 22)
Affinity DataIC50:  55nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRetinoic acid receptor RXR-alpha(Homo sapiens (Human))TBA
LigandPNGBDBM50445062(CHEMBL3098771)
Affinity DataIC50:  284nMAssay Description:Inhibition of RXRalpha (unknown origin)More data for this Ligand-Target Pair
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395801(US10308654, Example 29)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395799(US10308654, Example 27)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395798(US10308654, Example 26)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395797(US10308654, Example 25)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395796(US10308654, Example 24)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395795(US10308654, Example 23)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395793(US10308654, Example 21)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395790(US10308654, Example 18)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395789(US10308654, Example 17)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395788(US10308654, Example 16)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395787(US10308654, Example 15)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395786(US10308654, Example 14)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395785(US10308654, Example 13)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Changzhou Longthera Pharmaceuticals

US Patent
LigandPNGBDBM395792(US10308654, Example 20)
Affinity DataIC50:  550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetL-lactate dehydrogenase A chain(Homo sapiens (Human))
Capital Medical University

Curated by ChEMBL
LigandPNGBDBM50275213(CHEMBL4126939)
Affinity DataEC50:  670nMAssay Description:Inhibition of human LDH5 using pyruvate as substrate after 10 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetL-lactate dehydrogenase A chain(Homo sapiens (Human))
Capital Medical University

Curated by ChEMBL
LigandPNGBDBM50275214(CHEMBL4126746)
Affinity DataEC50:  390nMAssay Description:Inhibition of human LDH5 using pyruvate as substrate after 10 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial(Homo sapiens (Human))
Capital Medical University

Curated by ChEMBL
LigandPNGBDBM50525863(CHEMBL1708524)
Affinity DataEC50:  1.17E+4nMAssay Description:Inhibition of PDK1 (unknown origin) using PDCE1 as substrate incubated for 30 mins by kinase-Glo reagent based luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 59 total ) | Next | Last >>
Jump to: